TSE:TOS - TSO3 Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
C$0.88 -0.02 (-2.22 %)
(As of 07/20/2018 04:00 PM ET)
Previous CloseC$0.88
Today's RangeC$0.87 - C$0.91
52-Week RangeC$0.56 - C$3.27
Volume35,500 shs
Average Volume201,135 shs
Market CapitalizationC$105.96 million
P/E RatioN/A
Dividend YieldN/A
Beta1.11
TSO3 logoTSO3 Inc. engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices. Its principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States. The company also develops and sells the STERIZONE 125L+ sterilizer, which is designed for terminal sterilization of heat and moisture sensitive medical devices, and is intended for the reprocessing of general instruments, rigid channel instruments, and single/multi-channel rigid endoscopes, as well as short and long single/multi-channel flexible endoscopes. In addition, it provides product development services to medical device manufacturers and others that include hydrogen peroxide and ozone sterilization validation, compatibility testing, medical devices cleaning method development, and medical packaging compatibility verification services. The company was founded in 1998 and is headquartered in Quebec, Canada.

Receive TOS News and Ratings via Email

Sign-up to receive the latest news and ratings for TOS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange TSE
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolTSE:TOS
CUSIPN/A
Phone+1-418-6510003

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-34.69%
Return on Equity-48.85%
Return on Assets-28.90%

Miscellaneous

EmployeesN/A
Outstanding Shares92,891,000
Market CapC$105.96

TSO3 (TSE:TOS) Frequently Asked Questions

What is TSO3's stock symbol?

TSO3 trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TOS."

How were TSO3's earnings last quarter?

TSO3 Inc. (TSE:TOS) posted its earnings results on Tuesday, May, 8th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by $0.02. The company earned $0.32 million during the quarter. TSO3 had a negative net margin of 34.69% and a negative return on equity of 48.85%. View TSO3's Earnings History.

When is TSO3's next earnings date?

TSO3 is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for TSO3.

What price target have analysts set for TOS?

5 Wall Street analysts have issued 12-month price objectives for TSO3's stock. Their forecasts range from C$0.90 to C$2.75. On average, they anticipate TSO3's stock price to reach C$1.73 in the next twelve months. This suggests a possible upside of 96.6% from the stock's current price. View Analyst Ratings for TSO3.

What is the consensus analysts' recommendation for TSO3?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TSO3 in the last year. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."

Who are some of TSO3's key competitors?

Who are TSO3's key executives?

TSO3's management team includes the folowing people:
  • Mr. Richard M. Rumble, Chief Exec. Officer, Pres and Director (Age 59)
  • Mr. Glen Kayll, Chief Financial Officer (Age 49)
  • Mr. Harold R. Tessman, Chief Operations Officer
  • Mr. James Ralph Mills, VP of HR
  • Mr. Anan Natarajan, Sr. VP of Global Commercialization

Has TSO3 been receiving favorable news coverage?

News headlines about TOS stock have been trending positive on Saturday, according to Accern Sentiment. The research group scores the sentiment of press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. TSO3 earned a media sentiment score of 0.39 on Accern's scale. They also assigned media headlines about the company an impact score of 49.35 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of TSO3?

Shares of TOS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is TSO3's stock price today?

One share of TOS stock can currently be purchased for approximately C$0.88.

How big of a company is TSO3?

TSO3 has a market capitalization of C$105.96 million.

How can I contact TSO3?

TSO3's mailing address is 2505 Dalton Ave, QUEBEC, QC G1P 3S5, Canada. The company can be reached via phone at +1-418-6510003.


MarketBeat Community Rating for TSO3 (TSE TOS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  121 (Vote Outperform)
Underperform Votes:  115 (Vote Underperform)
Total Votes:  236
MarketBeat's community ratings are surveys of what our community members think about TSO3 and other stocks. Vote "Outperform" if you believe TOS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TOS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.